Monday

Cystine disease

Cystine disease is a lysosomal storage disease, due to the short arm of chromosome 17 of 13 positions (17p13) number of boxes gene defect causes the cysteine ​​(cystine) to carry out the transport of lysosomal unitary Each (transporter) dysfunction, making cystine accumulation in the cell lysosomes, and thus resulting in tissue and organ lesions.
DirectoryThe incidence of type inheritance pattern characterized by growth retardation clinical situation occurs other diagnostic treatment and prognosisType according to time of onset and severity of the disease can be divided into three types: one, nephropathy type / infantile (nephrotic cystinosis); Second, intermediate / juvenile (intermediate cystinosis); Third, non-nephrotic type / adult (non-nephrotic cystinosis ). Among nephropathy type / infantile most common symptoms are most severe.The incidence of disease incidence has been estimated as 1/200000. Bretagne region in France (Brittany), the study found the incidence of the disease in the region 1 / 26,000.Currently this disease has been listed as China's announcement of rare diseases, it is estimated that the incidence of Taiwan should be one ten thousandth or less.Mode of inheritance is autosomal recessive disease, which means that the parents of each gene with a mutation, regardless of gender will be the next generation of tires every chance of suffering from this disease a quarter.Clinical manifestations nephropathy type / infantile patients are usually asymptomatic newborn first few months, but in the 6-9 months old when that is gradually emerging anorexia, vomiting, polyuria, growth retardation situation, and the emergence of kidneys and other organs of the lesion . The main clinical manifestations are renal Fanconi syndrome.Fanconi syndrome (renal Fanconi syndrome):Often occurs in June a large, tubular unable to due to water, electrolytes, bicarbonate, phosphate, calcium, carnitine, molecules such as glucose and amino acid reabsorption, and the emergence polyuria, polydipsia, dehydration Even acidosis symptoms.Electrolytes and amino acids and other molecules loss would patients with a variety of ailments, including: (1) low-phosphate rickets, often causing the patient's pain when walking. (2) low blood calcium, causing limbs twitching, severe low will hinder the heart's normal conduction. (3) occasionally hyponatremia and hypomagnesemia from happening. (4) will be higher than the actual age of bone behind.Due to the gradual glomerular damage, poor growth and severe renal glomerular filtration rate decreased, 10-year-old kidney failure that may occur.Corneal cystine crystals (cornea) cystine crystals:Patients often appear in the 2-3 age symptoms of photophobia, after corneal examination, can be found in the cornea of ​​the eye cystine crystals (corneal crystals) can occur before age 1. Untreated nephropathy in patients with type often after 16 months old can be found in this characterization.Also often appear retinopathy (peripheral retinal lesions), repeated corneal injury (recurring) corneal erosion, low visual acuity change characterization. Some childhood eye disease that occurs in patients even lead to blindness.Growth retardation is usually found at six months oldA situation occurs that may arise hypothyroidism, pituitary gonadal function and insulin secretion disorders.Other normal intelligence, but may occur late in the disease and brain atrophy neurological lesions.Intermediate / juvenile relatively mild symptoms of kidney disease, occurrence time is late, usually in the 6-8 age of onset.Non nephropathy type / adult symptoms of this type for the eyes and bone marrow have cystine crystals, usually only appear photophobia symptoms.Diagnosis may use cysteine ​​protein binding technique (cystine binding protein assay) to detect blood leukocyte cystine (cystine) concentration; nephropathy type / infantile often normal value 50-100 times. This detection technology can also be used to detect fibrous tissue, conjunctival tissue and muscle intracellular homocysteine ​​levels. The first three months of pregnancy can also be from the skin, the cultured amniotic fluid cells or chorionic fibrous tissue cells for prenatal diagnosis.Treatment study found that homocysteine ​​(cysteamine tartaric acid, medicines called Cystagon) drug treatment, the preferred treatment for the disease cystine way, this a free state thiols, cystine structures can be dissolved from more than 90% of the cystine cells, will be able to effectively control the renal disease progression in patients with variant.Long-term active treatment can avoid or delay kidney failure, and the incidence of hypothyroidism, and can dissolve the cystine accumulation in muscle tissue to relieve symptoms and improve patient growth situation.Diagnosis, provide treatment as soon as possible; within one month after birth if that is underway, the treatment can often get the best results, and helps the growth of kidney and avoid deterioration of renal function. Found that long-term treatment, although they can not cure the disease, but can be avoided in patients with significant late complications.Side effects that may occur in nausea and vomiting, but may be due to drugs with unpleasant odors caused with taste; recent research suggests can be used with gastrointestinal medication ─ omeprazole, in order to improve on the stomach discomfort.It must be noted that, oral medications cysteine, are not intended to improve corneal cystine crystals, it is recommended that patients using cysteamine hydrobromide (cysteamine hydrochloride) eye drops, to within a few months to reduce corneal cystine crystals, a few weeks reduce eye sensitivity to light, dark or while wearing sunglasses, but also to reduce the sunlight brought photophobia situation.The main treatment goals for replenish electrolytes caused by kidney disease, loss of amino acids and other substances, including water, sodium, potassium, phosphorus, calcium, magnesium, vitamin Ḏ ... etc., the amount of intake required under depending on the patient's condition and the body should be regularly monitored in order to achieve the desired.In case of hypothyroidism, pituitary gonadal function problems such as endocrine disorders may accept the associated endocrine therapy.When the progressive deterioration of renal function outcome to renal failure, patients are usually required to undergo blood or peritoneal dialysis treatment, and may need to consider a kidney transplant. After kidney transplantation, even cystine crystals deposited in the kidney transplant, but still does not produce Fanconi syndrome may occur more frequently after transplantation rejection situations, patients need to track return visits regularly to provide immediate treatment

Raptor Pharmaceutical Corp

Novato, Jan. 11 / PRNewswire-PR Newswire / - Raptor Pharmaceutical Corp. (Hereinafter referred to as "Raptor" or the "Company") today announced its used to treat nephrotic cystinosis (referred to as "bladder histidine disease ") in patients with a proprietary sustained-release cysteamine bitartrate (referred to as" DR Cysteamine ") prototype formulation phase 2a clinical outcome. San Diego University of California (University of California) pediatrics expert Ranjan Dohil, MD, is the main sponsor of this study, the study in the United States, "Pediatrics" (Journal of Pediatrics) published, but also through http://www .ncbi.nlm.nih.gov/pubmed/19775699? itool = EntrezSystem2.PEntrez.Pubmed. Pubmed_ResultsPanel.Pubmed_RVDocSum & ordinalpos = 1 web.
(Icon: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO)

The Phase 2a study demonstrated for DR Cysteamine theory test, DR Cysteamine is the immediate release cysteamine bitartrate capsules gelatin beads Raptor's proprietary enteric release formulations. Immediate-release cysteamine bitartrate (referred to as "IR Cysteamine") is used for the treatment of cystinosis current standards. This result shows that DR Cysteamine twice daily doses, its DR Cysteamine in cystinosis prototype formulations can effectively maintain low levels of white blood cells (WBC) cystine (2.5 nmol cystine / 1 mg protein). The results also showed that if patients taking doses of DR Cysteamine in the original IR Cysteamine simply served on about 60% of the total dose, DR Cysteamine prototype equipped with convenient trough WBC cystine levels can be maintained at a satisfactory range.
Dohil said: "Because IR Cysteamine has been writing letters to patients cystine, causing poor treatment adherence to its extensive coverage of events, so we're looking to improve IR Cysteamine resistance and reduce their dosage requirements new drugs and we believe this will further promote the Phase 2a study of patients seeking cystine potential therapeutic solutions to our clinical trial results show that this release cysteamine drug formulation taken twice a day and its total daily doses doses lower than IR Cysteamine, can improve drug resistance and efficacy. Based on these results, I believe that Raptor's DR Cysteamine final formulation with improved patient Zheyi from cystine and its potential for long-term treatment. "

Cause of infantile cystinosis

(A) causes cystinosis in the male, Girls morbidity same. Parents can not be vertically inherited the disease to their children, but often multiple sibling incidence. Cystine disease is an autosomal recessive genetic disease, the patient was homozygous, their parents to carry the disease heterozygotes. The clinical disease with severe renal variant infants, young and adult patients with benign intermediate type 3, indicating that the genetic heterogeneity of the disease, while there is genetic heterogeneity.
(Two) the pathogenesis of intracellular lysosomal cystine deposition in confined and difficult with the extracellular exchange, but the biochemical mechanism is unknown; currently considered within the cell cystine calm reason, most likely cystine or cysteine ​​in the spaces between cells or abnormal intracellular translocation, resulting in deposition of cystine sick children in the liver, spleen, bone marrow, peripheral blood leukocytes, lymph nodes, kidney and cornea deposition. 1 cystinosis is characterized systemic tissues cystine crystal deposition, the deposition of parts of the reticuloendothelial cells of bone marrow, liver, spleen, lymph nodes, peripheral blood leukocytes, kidney medulla, cortex and mesangial , conjunctival and uveitis. (2) deposition of cystine kidney cause renal tissue damage caused by renal failure. Appearance pale kidney cortex and medulla unclear boundaries; microscopic structural damage nephron glomerular showed hyaline degeneration, renal tubular epithelial cells are normal dice-shaped cells are replaced. Becomes narrow and shorten the proximal tubule, was "swan neck" deformity.
Children with cystinosis symptoms
1 nephropathy type is mainly seen in children and infants.
(1) Early: initially presented with progressive renal injury related symptoms of polydipsia, polyuria, dehydration. A performance at the age of growth arrest, rickets, renal tubular acidosis and a variety of functional abnormalities of glycosuria, amino acids in urine, increased urinary potassium phosphate in urine and so on. Children with fair complexion, hair, pale yellow. Most serious occurred in teens photophobia, eye cornea and conjunctiva slit lamp examination showed scattered in a uniform wire-like reflective objects; addition, the retina can see the edge of hypopigmentation spots with irregular distribution, ranging from the size of the pigment silk, called "edge characteristic retinopathy," help cystine diagnosis.
(2) Late: Due to progressive glomerular injury, caused by reduced glomerular filtration rate, azotemia, electrolyte imbalance, metabolic acidosis, growth retardation, and other relevant clinical manifestations. With the progress of the disease, severe anemia, edema and other symptoms.
(2) benign type without retinopathy and renal insufficiency; corneal, bone marrow and white blood cells in cystine crystal deposition, but does not produce symptoms, this type of patients can adulthood.
3 intermediate, also known as delayed or young adults. Patients with renal insufficiency, the symptoms manifest themselves until adolescence, there is incomplete Fanconi syndrome and the slow progress of glomerular dysfunction.
According to clinical manifestations in children, the presence of vitamin D deficiency rickets, Fanconi syndrome, etc.; in the conjunctiva, cornea and surrounding white blood cells, bone marrow reticuloendothelial cells in the presence of cystine crystals. Deposition of cystine in the kidney as well as evidence of pathological changes characteristic of the disease can be diagnosed.
Children with cystinosis diagnosis
Children with cystinosis inspection laboratoryUrine contains a large number of cystine, lysine, arginine and ornithine. The average daily urinary excretion of cystine up to 730mg (normal maximum value of about 18mg / g urine creatinine). A urinary cystine crystals take morning urine checked for centrifugation, visible under the light microscope with benzene-type hexagonal tabular crystals similar. Crystallization occurs often show urinary cystine concentration exceeds 200 ~ 250mg / L. 2 cyanide nitroprusside test the stone into powder, put a little in a test tube, add 1 drop of concentrated ammonia, after the addition of a drop of 5% sodium cyanide, 5min after the addition of 3 drops of 5% sodium nitroprusside, such as Now the characteristic deep cherry red shown as positive, indicates the presence of cystine. However, the same type of cystine, pyruvate, all amino acids in urine and certain drugs was a false positive, attention should be identified. In addition, because of the urine row cystine can be presented volatility, should pay attention to false negative. 3 chromatographic quantitative determination of urine on the diagnosis and classification of help. Routine should be done renal B, X-ray, angiography and CT, to help diagnosis and differential diagnosis.
Differential diagnosis of children cystinosisCompared with other amino acids in urine disease identification, based on clinical and laboratory examination and more can be confirmed.
Children with cystinosis complications
Can occur dehydration, hypokalemia, metabolic acidosis, anemia, nutritional disorders, rickets, end-stage renal failure. Small number of patients hyperuricemia, hereditary hypocalcemia, hemophilia, muscular atrophy, hereditary pancreatitis, such as retinitis pigmentosa.
Children with cystinosis prevention and treatment of
(A) the treatment of this disease is hereditary diseases, no cure for. The main control cystine stone formation and its complications.
1 diet low methionine (cystine most important predecessor) diet, sometimes moderate decrease urinary cystine.
(2) increase the amount of water, especially at night, in order to prevent the precipitation of cystine crystals concentrate urine, the daily intake of water above at least 4L, dilute the concentration of the urinary cystine maintained at 250mg / L or less.
3 alkalization of urine can be served sodium citrate or sodium bicarbonate (10 ~ 38g / d) to alkaline urine (so that the urine pH> 7.5), can increase the solubility of cystine to prevent stone formation. General urinary pH 7.5, the solubility of cystine highest (about dissolving 250mg / L), but there is danger of promoting calcium phosphate deposition. Can also be taken at bedtime acetazolamide (vinegar azole sulfonamides) (250 ~ 500mg).
4 drug treatment
(1) penicillamine (D-penicillamine): is a β-dimethyl cysteine, which can reduce urinary cystine about 50% of the free, while soluble cysteine ​​reacts with cystine - Penicillium amine disulfide compounds from the urine, it can prevent stone formation. Usage: 1 ~ 2g / d, min to 4 times service. Often side effects of this drug, such as rash, fever, joint pain, bone marrow suppression, lupus reactions and kidney damage (nephrotic syndrome) and so on. Thus, the drug is only used for the general treatment of cystine stones can not be controlled and serious cases.
(2) the newer drugs: such as N-acetyl-D-penicillamine (N-acetyl-D-penicillamine), low toxicity, have the same effect.
(3) Tiopronin (Mercaptopropionylglycine): the role with penicillamine, but less toxic.
(4) dithiothreitol (DTT): to reduce the intracellular cystine.
(5) a mercapto ethylamine (cystine amine): to remove free intracellular cystine.
(6) large doses of vitamins: effects are not sure.
5 can be considered the treatment of kidney stones extracorporeal shock wave lithotripsy or stone surgery.
6 symptomatic treatment to maintain water balance, correct acidosis. Given large doses of vitamin D therapy rickets. Prevention and treatment of urinary tract infections, urinary tract obstruction.
7 dialysis and kidney transplantation then be uremia dialysis or kidney transplantation.
(1) dialysis therapy: although not remove cell and tissue deposition of cystine, it can continue to grow in patients with renal failure and renal transplant preparation.
(2) renal transplantation: postoperative symptoms improve, growth resumed. There are reports of renal transplantation can still found cystine deposition; kidney transplant long-term effects to be determined.
(Two) the prognosis of the disease with poor prognosis, more than before puberty develop into uremia and death.
Children with cystinosis care
Homocystinuria is a familial genetic disease, an autosomal recessive genetic disease, prevention measures may be hereditary disease preventive measures. To reduce the incidence of this disease, prevention should penetrate to prenatal pregnancy: premarital medical examination in the prevention of birth defects play an active role, the role depends on the inspection items and content, including serological tests (such as hepatitis B virus, Treponema pallidum, AIDS virus), reproductive system checks (such as screening for cervical inflammation), general physical examination (such as blood pressure, ECG), and asking a family history of the disease, such as personal medical history, genetic diseases do consulting work. Pregnant women try to avoid risk factors, including away from the smoke, alcohol, drugs, radiation, pesticides, noise, volatile harmful gases, toxic heavy metals. In the course of prenatal care during pregnancy need to be systematic screening for birth defects, including regular ultrasound, serological screening, etc., if necessary, carry chromosome. Once the abnormal results need to be clear whether you want to terminate the pregnancy; safety of the fetus in utero; existence after birth complications, whether to treat, the prognosis is how and so on. To take practical measures for diagnosis and treatment.
Please help Google Translate improve quality for your language here.

Recent information